医学
肝细胞癌
流行病学
肝硬化
非酒精性脂肪肝
死因
饮酒量
环境卫生
酒精性肝病
肝癌
疾病
癌症
癌症的病因
肝病
全球卫生
脂肪肝
肿瘤科
内科学
公共卫生
病理
酒
生物化学
化学
标识
DOI:10.1016/j.soc.2023.06.004
摘要
Globally, hepatocellular carcinoma (HCC) is a major cause of cancer-related death and a leading cause of morbidity and mortality in patients with chronic liver disease and cirrhosis. The predominant cause of HCC is shifting from viral to nonviral causes, in parallel with the high global prevalence of nonalcoholic fatty liver disease and increasing alcohol consumption in many countries. There have been promising recent advances in the treatment of all stages of HCC; however, improvements in early detection, increased utilization of HCC surveillance, and equitable access to HCC therapies are needed to curb increases in HCC mortality.
科研通智能强力驱动
Strongly Powered by AbleSci AI